HOUSE, PA — Johnson & Johnson has submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug ...

AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced interim safety and tolerability data from the ...

Northbound lane opening3; Southbound lane opening late January 2025 New carpool and high occupancy vehicle lanes built as ...

Fear not, festive friends – we've cracked the code with 100 presents that'll make gift-giving feel less like a psychological ...

New carpool and high occupancy vehicle lanes built as part of the Highway 101: Carpinteria to Santa Barbara Project will open this week and late January ...

NewAmsterdam Pharma's obicetrapib demonstrates strong phase 3 results. Discover why NAMS stock could rise as further studies ...

A new $31.1 million mental health facility at Gisborne Hospital will open by January 2025. The facility includes 10 beds, ...

54% of patients experience more than 2.5 years of durable hematocrit (Hct) control (<45%), decreased phlebotomy use, long-term tolerability, and improvements in patient-reported outcomes in patients ...